Centre For Cellular And Molecular Platforms - Due diligence report

A 360° intelligence report on Centre For Cellular And Molecular Platforms: trust score, financial health, credit view, compliance, directors…

2010-01-08 Bangalore, Karnataka Active Unlisted Active Compliant
CF Centre For Cellular And Molecular Platforms
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Centre For Cellular And Molecular Platforms — 360° Intelligence Report

Generated from MCA filings & public records
94/100
Trust Score
Low Risk

Centre For Cellular And Molecular Platforms is assessed as Low Risk with a Trust Score of 94/100. Centre For Cellular And Molecular Platforms is an active private not for profit company incorporated in 2010, operating in the Professional Services sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Centre For Cellular And Molecular Platforms snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
94/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
SHASHIDHARA SUBRAHMANYA LINGADAHALLI 01234567 Director 01/04/2018 6 yrs Approved
SATYAJIT SATYAPAL MAYOR 01234567 Director 01/04/2018 6 yrs Approved
TASLIMARIF TURABMIYA SAIYED 01234567 Director 01/04/2018 6 yrs Approved
TASLIMARIF TURABMIYA SAIYED 01234567 Director 01/04/2018 6 yrs Approved
SHRIKUMAR SURYANARAYAN 01234567 Director 01/04/2018 6 yrs Approved
MANOJ KUMAR 01234567 Director 01/04/2018 6 yrs Approved
SUBRAMANIAN RAMASWAMY 01234567 Director 01/04/2018 6 yrs Approved
  • 7 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)

Key managerial personnel: TASLIMARIF TURABMIYA SAIYED (CEO)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Net margin improved to 61%.
Operating for 16+ years.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence95/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment92/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view93/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 14 events
10 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
23 Sep 2024
Director ceased
SHASHIDHARA SUBRAHMANYA LINGADAHALLI
21 Sep 2024
Director appointed
SHASHIDHARA SUBRAHMANYA LINGADAHALLI (Director)
25 Jul 2022
Securities allotted
40 Equity Shares - 400.00 raised
23 Sep 2019
Director ceased
MANOJ KUMAR
20 Sep 2019
Director appointed
MANOJ KUMAR (Director)
22 Sep 2018
Director ceased
VIJAYRAGHAVAN KRISHNASWAMY
21 Apr 2017
Director appointed
TASLIMARIF TURABMIYA SAIYED (CEO)
04 Apr 2017
Director appointed
TASLIMARIF TURABMIYA SAIYED (Director)
19 Mar 2010
Director appointed
SHRIKUMAR SURYANARAYAN (Director)
Director appointed
SUBRAMANIAN RAMASWAMY (Director)
08 Jan 2010
Incorporated
Registered with Roc Bangalore
Director appointed
SATYAJIT SATYAPAL MAYOR (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
7 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Ce Comfort Engineers Private Limited U29253DL2012PTC230551 Delhi, Delhi, India
Webkorps Services India Private Limited U72900MP2022PTC059856 Indore, Madhya Pradesh, India
Labultima Process Technologies Private Limited U74999MH2016PTC272660 Palghar, Maharashtra, India
Acurus Solutions U72200TN1999PTC042640 Chennai, Tamil Nadu, India
Sai Corp Creations Private Limited U74999DL2013PTC258488 New Delhi, Delhi, India
Sage Automation Group (India) Private Limited U74999PN2014PTC151044 Haveli, Maharashtra, India
Exafluence Global Analytics Private Limited U72900KA2021FTC146166 Bangalore, Karnataka, India
Select Home Interior Designers Private Limited U74999KA2016PTC094372 Bangalore, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Centre For Cellular And Molecular Platforms before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Centre For Cellular And Molecular Platforms: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Centre For Cellular And Molecular Platforms - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 94/100, distress signals and MSME payment-delay disclosures - know whether Centre For Cellular And Molecular Platforms pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Centre For Cellular And Molecular Platforms - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Centre For Cellular And Molecular Platforms an active company?

Centre For Cellular And Molecular Platforms has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Centre For Cellular And Molecular Platforms financially healthy?

Centre For Cellular And Molecular Platforms has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Centre For Cellular And Molecular Platforms?

Its overall Trust Score is 94/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Centre For Cellular And Molecular Platforms?

See the directors and ownership sections above for board and shareholding detail. 7 active director(s) are on record.

Does Centre For Cellular And Molecular Platforms have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Centre For Cellular And Molecular Platforms up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Centre For Cellular And Molecular Platforms?

Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.